Research programme: oral insulin/insulin sensitiser - Diabetology

Drug Profile

Research programme: oral insulin/insulin sensitiser - Diabetology

Alternative Names: Combulin

Latest Information Update: 30 Sep 2015

Price : $50

At a glance

  • Originator Diabetology
  • Class Insulins
  • Mechanism of Action Ornithine decarboxylase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Type 2 diabetes mellitus

Most Recent Events

  • 30 Sep 2015 Preclinical development is ongoing in United Kingdom (Diabetology pipeline, September 2015)
  • 30 May 2005 Preclinical trials in Type-2 diabetes mellitus in United Kingdom (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top